IP Library › Granted Patent US 8,652,043
Granted Patent B2
US 8,652,043 · App. 13/555,057 · Granted Feb 18, 2014

Analyte monitoring device and methods of use

Inventors: Steven H. Drucker (Oakland, CA); Robert Y. Jin (Castro Valley, CA); Jeffery V. Funderburk (Fremont, CA)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,043
App. No.
13/555,057
Granted
Feb 18, 2014
Kind
B2
Abstract

An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.

Claims (26)

1. A glucose monitoring device, comprising:

a glucose sensor, at least a portion of which is adapted for implantation and contact with bodily fluid, the glucose sensor producing a signal representative of a level of glucose in the bodily fluid; and

a transmitter coupled to the glucose sensor so that the transmitter converts the signal representative of the level of glucose in the bodily fluid into a digital signal representing the level of glucose in the bodily fluid, assembles a plurality of data words into a data message, at least one of the data words containing data derived from the digital signal representing the level of glucose in the bodily fluid, each of the data words comprising a set of bits, wherein for at least two of the data words, the set of bits are organized into a set of data bits and a set of error correction bits, and transmits the plurality of data words in an interleaving sequence, wherein the interleaving sequence includes transmitting a first bit in each of the set of bits of each of the data words of the data message followed by transmitting a second bit in each of the set of bits of each of the data words of the data message until the assembled plurality of data words are transmitted.

2. The device of claim 1 , wherein the transmitter transmits each bit of each data word assembled into the data message starting with the least significant bit until the entire data message has been transmitted.

3. The device of claim 1 , wherein the transmitter is further configured to transmit the data words of the data message at a predetermined transmission rate in the interleaving sequence to reduce error in the transmitted data message.

4. The device of claim 1 , further including a processing unit operatively coupled to the transmitter.

5. The device of claim 1 , further including a current to frequency conversion unit operatively coupled to the transmitter, the current to frequency conversion unit configured to receive the signal representative of the level of glucose in the bodily fluid.

6. The device of claim 1 , wherein the transmitter is configured to transmit the data message to a remote location.

7. The device of claim 6 , wherein the remote location includes one or more of a receiver device or a drug administration system.

8. The device of claim 7 , wherein the transmitter is configured to transmit the data message using one or more of RF communication protocol, or infrared communication protocol.

9. The device of claim 1 , wherein the transmitter is configured to transmit the data message using frequency modulation.

10. The device of claim 1 , wherein the data message includes calibration data.

11. The device of claim 1 , wherein the transmitter is configured to encrypt the data message.

12. The device of claim 1 , wherein the glucose sensor comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises a glucose-responsive enzyme and a mediator, wherein at least one of the glucose-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the glucose-responsive enzyme and the mediator is crosslinked with the polymer.

13. A method comprising:

collecting, using a glucose sensor, an analog signal representing a level of glucose in a bodily fluid;

converting, using a transmitter, the analog signal into a digital signal representing the level of glucose in the bodily fluid;

assembling, using the transmitter, a plurality of data words into a data message, at least one of the data words containing data derived from the digital signal representing the level of glucose in the bodily fluid, each of the data words comprising a set of bits, wherein for at least two of the data words, the set of bits are organized into a set of data bits and a set of error correction bits; and

transmitting, using the transmitter, the data message, such that the plurality of data words assembled into the data message are transmitted in an interleaving sequence, wherein the interleaving sequence includes transmitting a first bit in each of the set of bits of each of the data words of the data message followed by transmitting a second bit in each of the set of bits of each of the data words of the data message until the assembled plurality of data words are transmitted.

14. The method of claim 13 , wherein each bit of each data word assembled into the data message is transmitted starting with the least significant bit until the entire data message has been transmitted.

15. The method of claim 13 , further including transmitting the data message to a remote location.

16. The method of claim 13 , further including transmitting the data message using one or more of RF communication protocol, or infrared communication protocol.

17. The method of claim 13 , further including transmitting the data message based on frequency modulation.

18. The method of claim 13 , wherein the data message includes calibration data.

19. The method of claim 13 , further including encrypting the data message.

20. The method of claim 13 , wherein the glucose sensor comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises a glucose-responsive enzyme and a mediator, wherein at least one of the glucose-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the glucose-responsive enzyme and the mediator is crosslinked with the polymer.

Assignments (2)
CHANGE OF NAME Recorded Nov 4, 2013
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 031579/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2013
From: HELLER, ADAM; DRUCKER, STEVEN H.; JIN, ROBERT Y.; FUNDERBURK, JEFFERY V.
To: THERASENSE, INC.
Reel/Frame 031540/0262 →
Continuity (3)
Continuation 10336195 · Jan 3, 2003
Continuation 09753746 · Jan 2, 2001
Related Publication 20120316412A1 · Dec 13, 2012